FDA Inspection 1240456 — Calyx Chemicals & Pharmaceuticals Limited

Calyx Chemicals & Pharmaceuticals Limited — FEI 3003721861

The FDA completed an inspection of Calyx Chemicals & Pharmaceuticals Limited on May 17, 2024 in Palghar. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
May 17, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Palghar (India)